The Impact of the Duration of Cardiac Troponin I Elevation on the Clinical Prognosis as Well as Incidence of New-Onset Atrial Fibrillation Respectively in Elderly Non-ST-Elevation Acute Myocardial Infarction Patients without PCI

References

• Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045. doi:10.1093/eurheartj/ehn579
   PubMed Web of Science ®Google Scholar
• Jabre P, Roger VL, Murad MH, et al. Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta⁃analysis. Circulation. 2011;123(15):1587–1593. doi:10.1161/CIRCULATIONAHA.110.986661
   PubMed Web of Science ®Google Scholar
• Bas HA, Aksoy F, Icli A, et al. The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction. Scand J Clin Lab Invest. 2017;77(2):77–82. doi:10.1080/00365513.2016.1244857
   PubMed Web of Science ®Google Scholar
• Bağcı A, Aksoy F. Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction. Biomark Med. 2021;15(10):731–739. doi:10.2217/bmm-2020-0838
   PubMed Web of Science ®Google Scholar
• Garg L, Agrawal S, Agarwal M, et al. Influence of atrial fibrillation on outcomes in patients who underwent primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction. Am J Cardiol. 2018;121:684–689. doi:10.1016/j.amjcard.2017.12.003
   PubMed Web of Science ®Google Scholar
• Zeymer U, Annemans L, Danchin N, et al. Impact of known or new‐onset atrial fibrillation on 2‐year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR registry. Eur Heart J Acute Cardiovasc Care. 2019;8:121–129. doi:10.1177/2048872618769057
   PubMed Web of Science ®Google Scholar
• Jin YY, Bai R, Ye M, et al. [Risk factors and prognoses analysis of new-onset atrial fibrillation in patients with acute myocardial infarction]. Zhonghua Nei Ke Za Zhi. 2019;58(2):133–138. Chinese. doi:10.3760/cma.j.issn.0578-1426.2019.02.010
   PubMedGoogle Scholar
• Obayashi Y, Shiomi H, Morimoto T, et al. Newly diagnosed atrial fibrillation in acute myocardial infarction. J Am Heart Assoc. 2021;10(18):e021417. doi:10.1161/JAHA.121.021417
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231–2264. doi:10.1016/j.jacc.2018.08.1038
   PubMed Web of Science ®Google Scholar
• Hindricks G. Corrigendum to: 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):546–547. doi:10.1093/eurheartj/ehaa798
   PubMed Web of Science ®Google Scholar
• Aydin S, Ugur K, Aydin S, et al. Biomarkers in acute myocardial infarction: current perspectives. Vasc Health Risk Manag. 2019;15:1–10. doi:10.2147/VHRM.S166157
   PubMed Web of Science ®Google Scholar
• Eggers KM, Oldgren J, Nordenskjöld A, et al. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J. 2004;148(4):574–581. doi:10.1016/j.ahj.2004.04.030
   PubMed Web of Science ®Google Scholar
• Ramasamy I. Biochemical markers in acute coronary syndrome. Clin Chim Acta. 2011;412(15–16):1279–1296. doi:10.1016/j.cca.2011.04.003
   PubMed Web of Science ®Google Scholar
• Park KC, Gaze DC, Collinson PO, et al. Cardiac troponins: from myocardial infarction to chronic disease. Cardiovasc Res. 2017;113(14):1708–1718. doi:10.1093/cvr/cvx183
   PubMed Web of Science ®Google Scholar
• Varghese T, Wenger NK. Non-ST elevation acute coronary syndrome in women and the elderly: recent updates and stones still left unturned. F1000Res. 2018;7:F1000Faculty Rev–1865. doi:10.12688/f1000research.16492.1
   Google Scholar
• Al-Otaiby MA, Al-Amri HS, Al-Moghairi AM. The clinical significance of cardiac troponins in medical practice. J Saudi Heart Assoc. 2011;23(1):3–11. doi:10.1016/j.jsha.2010.10.001
   PubMedGoogle Scholar
• Stoller M, Seiler C. Pathophysiology of coronary collaterals. Curr Cardiol Rev. 2014;10(1):38–56. doi:10.2174/1573403x113099990005
   PubMedGoogle Scholar
• Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion - a position statement from the heart failure association of the European society of cardiology. Eur J Heart Fail. 2019;21(2):137–155. doi:10.1002/ejhf.1369
   PubMed Web of Science ®Google Scholar
• van der Meer P, Gaggin HK, Dec GW. ACC/AHA versus ESC guidelines on heart failure: JACC guideline comparison. J Am Coll Cardiol. 2019;73(21):2756–2768. doi:10.1016/j.jacc.2019.03.478
   PubMed Web of Science ®Google Scholar
• Felker GM, Ellison DH, Mullens W, et al. Diuretic therapy for patients with heart failure: JACC state-of-The-art review. J Am Coll Cardiol. 2020;75(10):1178–1195. doi:10.1016/j.jacc.2019.12.059
   PubMed Web of Science ®Google Scholar
• Murphy SP, Ibrahim NE, Januzzi JL. Heart failure with reduced ejection fraction: a review. JAMA. 2020;324(5):488–504. doi:10.1001/jama.2020.10262
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Keskin M, Uzun AO, et al. Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction complicated with cardiogenic shock. Heart Lung Circ. 2019;28(2):237–244. doi:10.1016/j.hlc.2017.10.023
   PubMed Web of Science ®Google Scholar
• Hayıroğlu Mİ, Çınar T, Çinier G, et al. Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction. Aging Clin Exp Res. 2021. doi:10.1007/s40520-021-01960-6
   PubMedGoogle Scholar
• Zheng PP, Yao SM, Guo D, et al. Prevalence and prognostic value of heart failure stages: an elderly inpatient based cohort study. Front Med (Lausanne). 2021;8:639453. doi:10.3389/fmed.2021.639453
   PubMed Web of Science ®Google Scholar
• Sakata Y, Tsuji K, Nochioka K, et al. Transition of left ventricular ejection fraction in heart failure. Adv Exp Med Biol. 2018;1067:5–15. doi:10.1007/5584_2018_178
   PubMed Web of Science ®Google Scholar
• Gutierrez C, Blanchard DG. Diagnosis and treatment of atrial fibrillation. Am Fam Physician. 2016;94(6):442–452.
   PubMed Web of Science ®Google Scholar
• Aksoy F, Baş HA, Bağcı A, et al. The CHA2DS2-VASc score for predicting atrial fibrillation in patients presenting with ST elevation myocardial infarction: prospective observational study. Sao Paulo Med J. 2019;137(3):248–254. doi:10.1590/1516-3180.2018.0431140319
   PubMed Web of Science ®Google Scholar
• Oikonomou E, Zografos T, Papamikroulis GA, et al. Biomarkers in atrial fibrillation and heart failure. Curr Med Chem. 2019;26(5):873–887. doi:10.2174/0929867324666170830100424
   PubMed Web of Science ®Google Scholar
• Arslan A, Ozaydin M, Aksoy F, et al. Association between the use of renin-angiotensin system blockers and development of in-hospital atrial fibrillation in patients with ST-segment elevation myocardial infarction. Medicina (Kaunas). 2016;52(2):104–109. doi:10.1016/j.medici.2016.02.006
   PubMed Web of Science ®Google Scholar
• Tamariz L, Hernandez F, Bush A, et al. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2014;11(7):1102–1108. doi:10.1016/j.hrthm.2014.04.003
   PubMed Web of Science ®Google Scholar
• Pak S, Yatsynovich Y, Valencia D, et al. Serum uric acid and atrial fibrillation: meta-analysis. Crit Pathw Cardiol. 2018;17(3):161–166. doi:10.1097/HPC.0000000000000150
   PubMedGoogle Scholar
• Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta. 2018;484:150–163. doi:10.1016/j.cca.2018.05.046
   PubMed Web of Science ®Google Scholar
• Yu W, Cheng JD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020;11:582680. doi:10.3389/fphar.2020.582680
   PubMed Web of Science ®Google Scholar